Keyphrases
Polyclonal Antibody
100%
Herpes Simplex Virus Infection
100%
Ocular Herpes
100%
Herpes Simplex Virus
60%
Herpes Simplex Virus Type 1 (HSV-1)
60%
Current Treatment
40%
Trifluorothymidine
40%
Glycoprotein D
40%
Dose Effect
20%
Positive Control
20%
Recombinant
20%
Surface Glycoprotein
20%
Antiviral Efficacy
20%
Physiologic
20%
Treatment Choice
20%
New Antivirals
20%
Inoculation
20%
Scar
20%
Antiviral Agents
20%
Rabbit Model
20%
Blindness
20%
Slit Lamp Examination
20%
Keratitis
20%
Antiviral Treatment
20%
In Vivo Model
20%
Biomicroscopy
20%
Vision Loss
20%
DNA Analog
20%
Corneal Infection
20%
In Vivo Testing
20%
New Zealand White Rabbit
20%
Plaque Assay
20%
Virucidal Test
20%
Antiviral Assay
20%
Viral Culture
20%
Vero Cells
20%
African Green Monkey
20%
Kidney Fibroblasts
20%
Herpes Simplex Virus Keratitis
20%
Confluent Culture
20%
Neuroscience
Herpes Simplex Virus
100%
Herpes
100%
Polyclonal Antibody
100%
Antivirals
62%
In Vitro
50%
In Vivo
50%
Keratitis
25%
Glycoprotein D
25%
Trifluridine
25%
Vero Cell
12%
Corneal Infection
12%
Virus Recombinant
12%
Fibroblast
12%
Immunology and Microbiology
Polyclonal Antibody
100%
Herpes Simplex Virus
100%
Herpes Simplex
100%
Human Alphaherpesvirus 1
60%
Glycoprotein
40%
Keratitis
40%
Viral Disease
20%
Recombinant Virus
20%
Scar Formation
20%
Rabbit Model
20%
New Zealand White (Rabbit)
20%
Chlorocebus Aethiops
20%
Fibroblast
20%
Veterinary Science and Veterinary Medicine
Herpes Simplex Virus
100%
Trifluridine
25%
Fibroblast
12%